REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/08/2025
Voltar para busca
Dado oficial do USPTO
CARTIHEAL THE FUTURE OF JOINT REPAIR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
05/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35
Data de depósito
22/07/2019
Data de registro
04/08/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/08/2020
Última transação
05/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
IL
Examinador
VALLILLO, MELISSA
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "CARTIHEAL THE FUTURE OF JOINT REPAIR" and a design comprising a triangular shape with curved sides, with four curved bands within.
Titulares e representantes
Titulares
CARTIHEAL (2009) LTD.
Representantes
John L. Strand Wolf, Greenfield & Sacks, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalboneconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; veterinary preparations and substances for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalboneconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; medicines for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalboneconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; pharmaceutical preparations and medicines for preventing transplant rejection; chemicalbiochemical and biological substances for medical and veterinary purposesbody and cartilage implants comprising living tissue; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; nutritional supplementsvitaminsmineral supplements; medical plastersmaterials for dressingsgauze; medical adhesive tapedissolvable strips to stop bleeding from minor cuts and grazes; material for stopping teethdental wax; disinfectants for hygienic purposes; chemical preparations for pharmaceutical purposesfor geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalboneconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; preparations for destroying vermin; fungicidesherbicides
Classe 10
Surgical apparatus and instruments; medicaldental and veterinary apparatus and instruments for use in transplantation; artificial limbseyes and teeth; orthopedic articlesbracesjoint implants made from artificial materialsshoe insertswristneckbackankleknee and elbow supports and splints; bonejointanklekneeelbowleg and hand prostheses; surgical implants comprised of artificial materials; medical implantsbone and cartilage implants comprised of artificial materials; spinal implants comprised of artificial materials; suture materials; replacement parts for the aforementioned goods
Classe 35
Retail and wholesale servicesretail and wholesale stores featuring pharmaceutical preparationsmedicinesmedicalsurgical and dental apparatus and instrumentsnutritional supplementsvitaminsmineral supplements; advertising and business management services; business management; providing office functions; import agencies; sales promotion services; business consulting services; business information services; public relations services; electronic commerce servicesproviding information about products via telecommunication networks for advertising and sales purposes; procuring of contracts for purchase of advertising space; rental of advertising space; direct mail advertising; business networking; arranging of business introductions; conducting of exhibitions for business purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/02/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/02/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
20/10/2022
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
21/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/11/2020
FIMP
FINAL DISPOSITION PROCESSED
25/11/2020
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
25/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/11/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2020
PUBO
PUBLISHED FOR OPPOSITION
19/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
14/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
14/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/04/2020
DMCC
DATA MODIFICATION COMPLETED
10/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2020
ALIE
ASSIGNED TO LIE
09/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2020
RFNT
REFUSAL PROCESSED BY IB
14/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/11/2019
RFRR
REFUSAL PROCESSED BY MPU
22/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/11/2019
CNRT
NON-FINAL ACTION WRITTEN
01/11/2019
DOCK
ASSIGNED TO EXAMINER
29/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CARTIHEAL THE FUTURE OF JOINT REPAIR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.